PCASE1 ESTABLISHMENT OF A COST-EFFECTIVENESS (CE) THRESHOLD AT KING HUSSEIN CANCER CENTER- IMATINIB IN CHRONIC MYELOGENOUS LEUKEMIA (CML)

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)67137-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67137-9/fulltext
Title : PCASE1 ESTABLISHMENT OF A COST-EFFECTIVENESS (CE) THRESHOLD AT KING HUSSEIN CANCER CENTER- IMATINIB IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67137-9&doi=10.1016/S1098-3015(10)67137-9
First page :
Section Title :
Open access? : No
Section Order : 972
Categories :
Tags :
Regions :
ViH Article Tags :